Article ; Online: STAT1 Controls the Functionality of Influenza-Primed CD4 T Cells but Therapeutic STAT4 Engagement Maximizes Their Antiviral Impact.
Journal of immunology (Baltimore, Md. : 1950)
2023 Volume 210, Issue 9, Page(s) 1292–1304
Abstract: It is generally accepted that influenza A virus (IAV) infection promotes a Th1-like CD4 T cell response and that this effector program underlies its protective impact. Canonical Th1 polarization requires cytokine-mediated activation of the transcription ... ...
Abstract | It is generally accepted that influenza A virus (IAV) infection promotes a Th1-like CD4 T cell response and that this effector program underlies its protective impact. Canonical Th1 polarization requires cytokine-mediated activation of the transcription factors STAT1 and STAT4 that synergize to maximize the induction of the "master regulator" Th1 transcription factor, T-bet. Here, we determine the individual requirements for these transcription factors in directing the Th1 imprint primed by influenza infection in mice by tracking virus-specific wild-type or T-bet-deficient CD4 T cells in which STAT1 or STAT4 is knocked out. We find that STAT1 is required to protect influenza-primed CD4 T cells from NK cell-mediated deletion and for their expression of hallmark Th1 attributes. STAT1 is also required to prevent type I IFN signals from inhibiting the induction of the Th17 master regulator, Rorγt, in Th17-prone T-bet-/- cells responding to IAV. In contrast, STAT4 expression does not appreciably impact the phenotypic or functional attributes of wild-type or T-bet-/- CD4 T cell responses. However, cytokine-mediated STAT4 activation in virus-specific CD4 T cells enhances their Th1 identity in a T-bet-dependent manner, indicating that influenza infection does not promote maximal Th1 induction. Finally, we show that the T-bet-dependent protective capacity of CD4 T cell effectors against IAV is optimized by engaging both STAT1 and STAT4 during Th1 priming, with important implications for vaccine strategies aiming to generate T cell immunity. |
---|---|
MeSH term(s) | Mice ; Animals ; Humans ; CD4-Positive T-Lymphocytes ; Antiviral Agents/metabolism ; Influenza, Human ; T-Box Domain Proteins/metabolism ; Interferon-gamma/metabolism ; Transcription Factors/metabolism ; Th1 Cells ; STAT4 Transcription Factor/metabolism ; Cell Differentiation ; STAT1 Transcription Factor/metabolism |
Chemical Substances | Antiviral Agents ; T-Box Domain Proteins ; Interferon-gamma (82115-62-6) ; Transcription Factors ; STAT4 Transcription Factor ; Stat1 protein, mouse ; STAT1 Transcription Factor ; Stat4 protein, mouse |
Language | English |
Publishing date | 2023-03-21 |
Publishing country | United States |
Document type | Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural |
ZDB-ID | 3056-9 |
ISSN | 1550-6606 ; 0022-1767 ; 1048-3233 ; 1047-7381 |
ISSN (online) | 1550-6606 |
ISSN | 0022-1767 ; 1048-3233 ; 1047-7381 |
DOI | 10.4049/jimmunol.2200407 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Ud II Zs.37: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
|||
Zs.MG 28: Show issues |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.